K Okajima
About
In The Last Decade
K Okajima
16 papers receiving 309 citations
Peers
Comparison fields: 5 of 32
- Pulmonary and Respiratory Medicine 300
- Gastroenterology 163
- Surgery 142
- Oncology 53
- Molecular Biology 10
Countries citing papers authored by K Okajima
This map shows the geographic impact of K Okajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Okajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Okajima more than expected).
Fields of papers citing papers by K Okajima
This network shows the impact of papers produced by K Okajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Okajima. The network helps show where K Okajima may publish in the future.
Co-authorship network of co-authors of K Okajima
This figure shows the co-authorship network connecting the top 25 collaborators of K Okajima. A scholar is included among the top collaborators of K Okajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Okajima. K Okajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | General and specific prognostic factors of early gastric carcinoma treated with curative surgery. | 34 |
| 2 | [A cooperative study on concomitant with low-dose divided administration of cisplatin (CDDP) and sustained drip infusion of 5-fluorouracil (5-FU) for unresectable advanced gastric cancer. Osaka Cisplatin Gastric Cancer Study Group]. | 1 |
| 3 | 16 | |
| 4 | Risk factors of esophagojejunal anastomotic leakage after total gastrectomy for gastric cancer. | 31 |
| 5 | 187 | |
| 6 | [Overview of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer]. | 5 |
| 7 | 44 | |
| 8 | [Clinical significance of measurement of nuclear DNA content in breast cancer]. | 1 |
| 9 | [A case of advanced gastric cancer with Virchow's node metastasis, responding to concomitant plasma exchange and immunochemotherapy]. | 2 |
| 10 | [Malignancy grading in breast cancer as assessed by nuclear DNA content]. | 2 |
| 11 | [A case of ischemic lesion in the large intestine associated with Buerger's disease]. | 2 |
| 12 | [Nuclear DNA content in breast cancer--relation between ploidy and lymph node metastasis]. | 2 |
| 13 | [Relationship between hormone receptors in human breast cancer and nuclear grade]. | 1 |
| 14 | [A case of malignant lymphoma (Hodgkin's disease) in the stomach with hypoproteinemia (author's transl)]. | 2 |
| 15 | 1 | |
| 16 | [Extent of curative resection of gastric cancer and the other factors affecting prognosis]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.